Trial Profile
Clinical Trials Insight: 700013449
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Jun 2006
Price :
$35
*
At a glance
- Drugs Resveratrol (Primary)
- Indications Cancer metastases; Colorectal cancer; Multiple myeloma; Multiple sclerosis; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Sirtris
- 20 Jun 2006 New trial record.